SAN DIEGO, Calif. — VedaBio, the biotechnology company leading a paradigm-shift in molecular detection, today announced the formation of its scientific advisory board (SAB) comprised of world class academic and industry experts Rashid Bashir, PhD, Daniel Durocher, PhD, Patrick Hsu, PhD and David Perlin, PhD. VedaBio launched in October with initial funding of over $40 Million backed […]

Former lead investor joins business full-time bringing long track record in healthcare technology London, UK — Automata Technologies (‘Automata’ or the ‘Company’), a leading automation company powering life sciences labs, has appointed Joe Stringer Executive Chairman and Director of Corporate Development (EMEA) for the UK and EMEA. Following Automata’s recent $40m fundraise, the appointment comes as it accelerates its […]

Former Quantapore founder and CEO brings 20 years of proteomics and genomics industry experience to company developing a platform for comprehensively quantifying the proteome SEATTLE — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the expansion of its research and development senior […]

Life Sciences Pioneer Todd Dickinson, Ph.D., Appointed as CEO; Spatial Biology Innovator Ye Fu, PhD., Appointed as CTO Boston – Stellaromics, a leading provider of in situ spatial multi-omics technology, today announced that the company has raised $25 million in a Series A financing round. The Series A financing round included Plaisance Capital Management and […]

Global business leader to serve as executive director & strategic advisor to Opencell Technologies as it develops and commercializes its proprietary technology platform for continuous and scalable transfection that opens new frontiers for cellular engineering in emerging cell & gene therapy and synthetic biology markets. ST. LOUIS — OpenCell Technologies, a leader in pioneering the development and […]

WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher” or the “Company”), a leading global life sciences and diagnostics innovator, today announced that Christopher Riley has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility for its Biotechnology business, effective January 1, 2024. Mr. Riley, currently Vice President and Group Executive of Danaher’s […]

FARMINGDALE, NY, —  Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “the Company”), a leading life sciences company, announced today that Steven J. Pully has been appointed to the Company’s Board of Directors effective October 26, 2023. Mr. Pully will assume the role of Chairperson of the Board, and Chair of the Audit Committee as well. “In […]

THOUSAND OAKS, Calif. – The Board of Directors of Teledyne Technologies Incorporated (NYSE:TDY) announced today that Robert Mehrabian will be named Executive Chairman, effective January 1, 2024. As Executive Chairman, Dr. Mehrabian will remain actively involved with the company with a particular focus on strategy, technology, mergers and acquisitions and margin expansion programs. Dr. Mehrabian’s […]

Jonathan Pratt to Step Down to Pursue an External Opportunity Christos Ross Named Interim Senior Vice President of the Waters Division MILFORD, Mass. — Waters Corporation (NYSE:WAT) today announced that Jonathan (“Jon”) Pratt has decided to step down from his role as Senior Vice President of the Waters Division, to pursue an external opportunity. He will […]

Company appoints Jon Murray as VP Sales, Colleen McMillen as VP Marketing, and Dave Anstey as VP Pharma Business Development Ann Arbor, MI — Genomenon®, Inc., a leading genomic intelligence company, has announced new executive appointments for its sales and marketing team as the company continues to expand its footprint across clinical diagnostics and pharmaceutical markets. These […]